RenovoRx regains Nasdaq compliance with $1 minimum bid price rule - RNXT News | RalliesRenovoRx regains Nasdaq compliance with $1 minimum bid price rule
R
RNXT• Nasdaq compliance regained
- RenovoRx regained Nasdaq compliance with the $1 minimum bid price rule, removing a key listing-risk overhang.
- Nasdaq confirmed the stock closed at $1 or higher for 10 straight sessions from Aug. 6, 2026 through Aug. 19, 2026.
- The company had received a deficiency notice on Dec. 31, 2025 following 30 consecutive business days below $1.
